Synthesis and optimization of novel (3S,5R)-5-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)piperidine-3-carboxamides as orally active renin inhibitors

被引：9

作者：

Mori, Yutaka ^{[1
]}

Ogawa, Yasuyuki ^{[2
]}

Mochizuki, Akiyoshi ^{[3
]}

Nakamura, Yuji ^{[3
]}

Fujimoto, Teppei ^{[3
]}

Sugita, Chie ^{[3
]}

Miyazaki, Shojiro ^{[3
]}

Tamaki, Kazuhiko ^{[3
]}

Nagayama, Takahiro ^{[4
]}

Nagai, Yoko ^{[5
]}

Inoue, Shin-ichi ^{[5
]}

Chiba, Katsuyoshi ^{[6
]}

Nishi, Takahide ^{[7
]}

机构：

[1] Daiichi Sankyo Co Ltd, New Modal Res Labs, Shinagawa Ku, Tokyo 1408710, Japan

[2] Daiichi Sankyo Co Ltd, Venture Sci Labs, Shinagawa Ku, Tokyo 1408710, Japan

[3] Daiichi Sankyo Co Ltd, Med Chem Res Labs, Shinagawa Ku, Tokyo 1408710, Japan

[4] Daiichi Sankyo Co Ltd, Cardiovasc Metabol Res Labs, Shinagawa Ku, Tokyo 1408710, Japan

[5] Daiichi Sankyo Co Ltd, Drug Metab & Pharmacokinet Res Labs, Shinagawa Ku, Tokyo 1408710, Japan

[6] Daiichi Sankyo Co Ltd, Med Safety Res Labs, Edogawa Ku, Tokyo 1348630, Japan

[7] Daiichi Sankyo India Pharma Pvt Ltd, Daiichi Sankyo Life Sci Res Ctr India, Gurgaon 122015, Haryana, India

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2013年 / 21卷 / 18期

关键词：

Hypertension; Renin; Piperidine; Ketopiperazine; TRANSGENIC RATS; BLOOD-PRESSURE; DISCOVERY; DESIGN; ALISKIREN; POTENT; MARMOSETS; DS-8108B;

D O I：

10.1016/j.bmc.2013.06.057

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

We report synthesis and optimization of a series of (3S,5R)-5-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)piperidine-3-carboxamides as renin inhibitors. Chemical modification of P-1', P-2' and P-3 portions led to a promising 3,5-disubstituted piperidine 32o showing high renin inhibitory activity and favorable oral exposure in both rats and cynomolgus monkeys with acceptable CYP and hERG current inhibition. Compound 32o exhibited a significant blood pressure lowering effect by oral administration in two hypertensive animal models, double transgenic rats and furosemide pretreated cynomolgus monkeys. (C) 2013 Elsevier Ltd. All rights reserved.

引用

页码：5907 / 5922

页数：16

共 24 条

[11] MAINTENANCE OF BLOOD-PRESSURE BY THE RENIN-ANGIOTENSIN SYSTEM IN NORMAL MAN [J].

MACGREGOR, GA ;

MARKANDU, ND ;

ROULSTON, JE ;

JONES, JC ;

MORTON, JJ .

NATURE, 1981, 291 (5813) :329-331

[12] Structural modification of the P2′ position of 2,7-dialkyl-substituted 5(S)-Amino-4(S)-hydroxy-8-phenyl-octanecarboxamides:: The discovery of aliskiren, a potent nonpeptide human renin inhibitor active after once daily dosing in marmosets [J].

Maibaum, Juergen ;

Stutz, Stefan ;

Goeschke, Richard ;

Rigollier, Pascal ;

Yamaguchi, Yasuchika ;

Cumin, Frederic ;

Rahuel, Joseph ;

Baum, Hans-Peter ;

Cohen, Nissim-Claude ;

Schnell, Christian R. ;

Fuhrer, Walter ;

Gruetter, Markus G. ;

Schilling, Walter ;

Wood, Jeanette M. .

JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (20) :4832-4844

[13] Piperidine renin inhibitors:: from leads to drug candidates [J].

Märki, HP ;

Binggeli, A ;

Bittner, B ;

Bohner-Lang, V ;

Breu, V ;

Bur, D ;

Coassolo, P ;

Clozel, JP ;

D'Arcy, A ;

Doebeli, H ;

Fischli, W ;

Funk, C ;

Foricher, J ;

Giller, T ;

Grüninger, F ;

Guenzi, A ;

Güller, R ;

Hartung, T ;

Hirth, G ;

Jenny, C ;

Kansy, M ;

Klinkhammer, U ;

Lave, T ;

Lohri, B ;

Luft, FC ;

Mervaala, EM ;

Müller, DN ;

Müller, M ;

Montavon, F ;

Oefner, C ;

Qiu, C ;

Reichel, A ;

Sanwald-Ducray, P ;

Scalone, M ;

Schleimer, M ;

Schmid, R ;

Stadler, H ;

Treiber, A ;

Valdenaire, O ;

Vieira, E ;

Waldmeier, P ;

Wiegand-Chou, R ;

Wilhelm, M ;

Wostl, W ;

Zell, M ;

Zell, R .

FARMACO, 2001, 56 (1-2) :21-27

[14] Design and discovery of new (3S,5R)-5-[4-(2-chlorophenyl)-2,2-dimethyl-5-oxopiperazin-1-yl]piperidine-3-carboxamides as potent renin inhibitors [J].

Mori, Yutaka ;

Ogawa, Yasuyuki ;

Mochizuki, Akiyoshi ;

Nakamura, Yuji ;

Sugita, Chie ;

Miyazaki, Shojiro ;

Tamaki, Kazuhiko ;

Matsui, Yumi ;

Takahashi, Mizuki ;

Nagayama, Takahiro ;

Nagai, Yoko ;

Inoue, Shin-ichi ;

Nishi, Takahide .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (24) :7677-7682

[15] Lead optimization of 5-amino-6-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)-4-hydroxyhexanamides to reduce a cardiac safety issue: Discovery of DS-8108b, an orally active renin inhibitor [J].

Nakamura, Yuji ;

Fujimoto, Teppei ;

Ogawa, Yasuyuki ;

Namiki, Hidenori ;

Suzuki, Sayaka ;

Asano, Masayoshi ;

Sugita, Chie ;

Mochizuki, Akiyoshi ;

Miyazaki, Shojiro ;

Tamaki, Kazuhiko ;

Nagai, Yoko ;

Inoue, Shin-ichi ;

Nagayama, Takahiro ;

Kato, Mikio ;

Chiba, Katsuyoshi ;

Takasuna, Kiyoshi ;

Nishi, Takahide .

BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (11) :3175-3196

[16] Discovery of DS-8108b, a Novel Orally Bioavailable Renin Inhibitor [J].

Nakamura, Yuji ;

Fujimoto, Teppei ;

Ogawa, Yasuyuki ;

Sugita, Chie ;

Miyazaki, Shojiro ;

Tamaki, Kazuhiko ;

Takahashi, Mizuki ;

Matsui, Yumi ;

Nagayama, Takahiro ;

Manabe, Kenichi ;

Mizuno, Makoto ;

Masubuchi, Noriko ;

Chiba, Katsuyoshi ;

Nishi, Takahide .

ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (09) :754-758

[17] Design and optimization of novel (2S,4S,5S)-5-amino-6-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)-4-hydroxy-2-isopropylhexanamides as renin inhibitors [J].

Nakamura, Yuji ;

Sugita, Chie ;

Meguro, Masaki ;

Miyazaki, Shojiro ;

Tamaki, Kazuhiko ;

Takahashi, Mizuki ;

Nagai, Yoko ;

Nagayama, Takahiro ;

Kato, Mikio ;

Suemune, Hiroshi ;

Nishi, Takahide .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (14) :4561-4566

[18] A highly reactive and enantioselective bifunctional organocatalyst for the methanolytic desymmetrization of cyclic anhydrides: Prevention of catalyst aggregation [J].

Oh, Sang Ho ;

Rho, Ho Sik ;

Lee, Ji Woong ;

Lee, Je Eun ;

Youk, Sung Hoon ;

Chin, Jik ;

Song, Choong Eui .

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2008, 47 (41) :7872-7875

[19] Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats [J].

Pilz, B ;

Shagdarsuren, E ;

Wellner, M ;

Fiebeler, A ;

Dechend, R ;

Gratze, P ;

Meiners, S ;

Feldman, DL ;

Webb, RL ;

Garrelds, IM ;

Danser, AHJ ;

Luft, FC ;

Müller, DN .

HYPERTENSION, 2005, 46 (03) :569-576

[20] Structure-based drug design:: the discovery of novel nonpeptide orally active inhibitors of human renin [J].

Rahuel, J ;

Rasetti, V ;

Maibaum, J ;

Rüeger, H ;

Göschke, R ;

Cohen, NC ;

Stutz, S ;

Cumin, F ;

Fuhrer, W ;

Wood, JM ;

Grütter, MG .

CHEMISTRY & BIOLOGY, 2000, 7 (07) :493-504

← 1 2 3 →